(Q64988897)

2 July 2019

title

Failure of specific adoptive immunotherapy owing to survival and outgrowth of variant cells. (English)

1 reference

2 July 2019

1 reference

D L Hines

1

1 reference

2 July 2019

publication date

1 January 1989

1 reference

2 July 2019

Cancer Immunology, Immunotherapy

published in

1 reference

2 July 2019

volume

28

1 reference

2 July 2019

issue

4

1 reference

2 July 2019

page(s)

241-247

1 reference

2 July 2019

https://scigraph.springernature.com/pub.10.1007/bf00205232

exact match

0 references

cites work

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression

1 reference

12 December 2020

Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones

1 reference

12 December 2020

T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases

1 reference

12 December 2020

Differentiation of Abelson murine leukemia virus-infected promonocytic leukemia cells

1 reference

12 December 2020

Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity

1 reference

12 December 2020

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

12 December 2020

Specificity of adoptive chemoimmunotherapy of established syngeneic tumors

1 reference

12 December 2020

Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade

1 reference

12 December 2020

A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate

1 reference

12 December 2020

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

1 reference

12 December 2020

Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells

1 reference

12 December 2020

Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2

1 reference

12 December 2020

Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity

1 reference

12 December 2020

Intratumor immunologic heterogeneity

1 reference

12 December 2020

Abnormal migration of T lymphocyte clones

1 reference

12 December 2020

Potential for specific cancer therapy with immune T lymphocytes

1 reference

12 December 2020

?-Irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells

1 reference

12 December 2020

In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma

1 reference

12 December 2020

Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression

1 reference

12 December 2020

The Forty-Year-Old Mutation Theory of Lurla and Delbrück and Its Pertinence to Cancer Chemotherapy

1 reference

12 December 2020

Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes

1 reference

12 December 2020

The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy

1 reference

12 December 2020

Specificity of the T Cells That Mediate and Suppress Adoptive Immunotherapy of Established Tumors

1 reference

12 December 2020

Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations

1 reference

12 December 2020

Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells

1 reference

12 December 2020

Regression of established intradermal tumors and lymph node metastases in guinea pigs after systemic transfer of immune lymphoid cells

1 reference

12 December 2020

Adoptive immunotherapy of newly induced murine sarcomas

1 reference

12 December 2020

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 reference

12 December 2020

Progressive growth of immunogenic tumors: relationship between susceptibility of ascites P815 tumor cells to T-cell-mediated lysis and immune destruction in vivo.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00205232

1 reference

2 July 2019

Dimensions Publication ID

1040518464

0 references

1 reference

2 July 2019